ArticleNature communications2026

TRIM13 in situ engineering boosts anti-inflammatory capacity of CAR-Ms for liver fibrosis therapy.

Jinxin Gao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.